This week: Reversed ageing, pig organs, the future of humankind and citizen scientists using genetics to solve past crimes.
Scientists have created a new way to view proteins inside human cells. The method allows an electron microscope to view proteins precisely, unlike current methods.
Researchers have come up with a tool that offers a means of control over engineered cells, and it comes from a seemingly unlikely source — the hepatitis C genome.
Researchers at Caltech have developed an artificial neural network made out of DNA that can solve a classic machine learning problem: Correctly identifying handwritten numbers.
Chinese investors have poured more money into the US biotech market in the first six months of 2018 than they did in the entirety of last year.
Why are consumers so reluctant to embrace genetically modified foods? A new study suggests agricultural biotech companies are failing to show consumers a personal benefit to buying GM foods.
Scientists have taken a significant step toward developing a new vaccine for malaria, revealing for the first time an ‘atomic-scale’ blueprint of how the parasite invades human cells.
Researchers have developed a type of personalised machine learning that helps robots estimate the engagement and interest of each a child during autism therapy, using data that are unique to that child.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.
European genetics blockchain company, DNAtix, have announced the pilot of their blockchain-based infrastructure and ecosystem for genetic testing, services and research.
By analysing more than 125 existing datasets, researchers have revealed that DIP-seq, one of the most widely used methods in epigenetics research, commonly detected DNA sequences that did not have any epigenetic marks.